Market revenue in 2023 | USD 15,943.6 million |
Market revenue in 2030 | USD 27,638.4 million |
Growth rate | 8.2% (CAGR from 2023 to 2030) |
Largest segment | Services |
Fastest growing segment | Equipment |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Equipment, Services |
Key market players worldwide | B. Braun, Abbott Laboratories, Sunrise Medical, 3M Co, Baxter International Inc, Medtronic PLC, Cardinal Health Inc, Roche Holding AG ADR, Air Liquide SA, Amedisys Inc, Fresenius Medical Care AG, Arkray, Becton Dickinson & Co, OMRON Corp, Drive Medical, GE Aerospace, Medline Industries, Koninklijke Philips NV, Johnson & Johnson, Linde PLC, Vygon, Teleflex Inc, Moog Inc A, Fresenius SE & Co KGaA, Bayer AG, UnitedHealth Group Inc, Brookdale Senior Living Inc, Sunrise Senior Living, Genesis Healthcare Inc Class A, Extendicare Inc, Sonida Senior Living Inc, Home Instead |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to home healthcare market will help companies and investors design strategic landscapes.
Services was the largest segment with a revenue share of 84.29% in 2023. Horizon Databook has segmented the Japan home healthcare market based on equipment, services covering the revenue growth of each sub-segment from 2018 to 2030.
Japan is one of the lucrative markets for Home Healthcare in the Asia Pacific region. Various factors such as availability of advanced products, growing awareness regarding patient monitoring devices, and presence of well-established companies are expected to boost the market growth. Cardiovascular disease is a major cause of mortality and morbidity in Japan.
According to the Ministry of Health, Labour and Welfare of Japan, approximately 162 men per 100,000 population died due to heart disease in Japan, in 2018, accounting for an increase from approximately 135 men per 100,000 inhabitants in 2007. Heart diseases, apart from hypertensive heart diseases, were the second leading cause of death in the country's male population in 2018, after malignant neoplasms.
Therefore, the increasing prevalence of such diseases is anticipated to boost the market demand for Home Healthcare over the forecast period. Investments by several companies in developing advanced products and greater adoption of new technology as compared to other low-income Asian countries are among the factors anticipated to drive the market during the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan home healthcare market , including forecasts for subscribers. This country databook contains high-level insights into Japan home healthcare market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account